349 related articles for article (PubMed ID: 34170670)
21. Protective Effects of
Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
[TBL] [Abstract][Full Text] [Related]
22. β-caryophyllene, a dietary phytocannabinoid attenuates oxidative stress, inflammation, apoptosis and prevents structural alterations of the myocardium against doxorubicin-induced acute cardiotoxicity in rats: An in vitro and in vivo study.
Al-Taee H; Azimullah S; Meeran MFN; Alaraj Almheiri MK; Al Jasmi RA; Tariq S; Ab Khan M; Adeghate E; Ojha S
Eur J Pharmacol; 2019 Sep; 858():172467. PubMed ID: 31216443
[TBL] [Abstract][Full Text] [Related]
23. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Sun Z; Lu W; Lin N; Lin H; Zhang J; Ni T; Meng L; Zhang C; Guo H
Biochem Pharmacol; 2020 May; 175():113888. PubMed ID: 32112883
[TBL] [Abstract][Full Text] [Related]
24. All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression.
Khafaga AF; El-Sayed YS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):59-70. PubMed ID: 29085977
[TBL] [Abstract][Full Text] [Related]
25. Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro.
Wang C; Hu L; Guo S; Yao Q; Liu X; Zhang B; Meng X; Yang X
Toxicology; 2021 Aug; 460():152881. PubMed ID: 34358621
[TBL] [Abstract][Full Text] [Related]
26. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
27. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
El-Said NT; Mohamed EA; Taha RA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
[TBL] [Abstract][Full Text] [Related]
28. Disruption of the Keap1/Nrf2-Antioxidant Response System After Chronic Doxorubicin Exposure In Vivo.
Nordgren KKS; Wallace KB
Cardiovasc Toxicol; 2020 Dec; 20(6):557-570. PubMed ID: 32500386
[TBL] [Abstract][Full Text] [Related]
29. Ameliorative Effect of Cardamom Aqueous Extract on Doxorubicin-Induced Cardiotoxicity in Rats.
Abu Gazia M; El-Magd MA
Cells Tissues Organs; 2018; 206(1-2):62-72. PubMed ID: 30716735
[TBL] [Abstract][Full Text] [Related]
30. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
[TBL] [Abstract][Full Text] [Related]
31. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
32. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis.
Hajra S; Basu A; Singha Roy S; Patra AR; Bhattacharya S
Free Radic Res; 2017 Oct; 51(9-10):812-827. PubMed ID: 28922986
[TBL] [Abstract][Full Text] [Related]
34. β-LAPachone ameliorates doxorubicin-induced cardiotoxicity via regulating autophagy and Nrf2 signalling pathways in mice.
Nazari Soltan Ahmad S; Sanajou D; Kalantary-Charvadeh A; Hosseini V; Roshangar L; Khojastehfard M; Haiaty S; Mesgari-Abbasi M
Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):364-373. PubMed ID: 31630478
[TBL] [Abstract][Full Text] [Related]
35. Galangin attenuates doxorubicin-induced cardiotoxicity via activating nuclear factor erythroid 2-related factor 2/heme oxygenase 1 signaling pathway to suppress oxidative stress and inflammation.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Yang Y; Lan C
Phytother Res; 2023 Dec; 37(12):5854-5870. PubMed ID: 37655750
[TBL] [Abstract][Full Text] [Related]
36. Selenium Attenuates Doxorubicin-Induced Cardiotoxicity Through Nrf2-NLRP3 Pathway.
Yang HB; Lu ZY; Yuan W; Li WD; Mao S
Biol Trace Elem Res; 2022 Jun; 200(6):2848-2856. PubMed ID: 34462843
[TBL] [Abstract][Full Text] [Related]
37. Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-α.
Ma T; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
Mol Biol Rep; 2019 Feb; 46(1):105-118. PubMed ID: 30362071
[TBL] [Abstract][Full Text] [Related]
38.
Zhou P; Gao G; Zhao CC; Li JY; Peng JF; Wang SS; Song R; Shi H; Wang L
Pharm Biol; 2022 Dec; 60(1):638-651. PubMed ID: 35298357
[TBL] [Abstract][Full Text] [Related]
39. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
40. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
El-Ela SRA; Zaghloul RA; Eissa LA
Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]